GW7845 is an orally active, non-thiazolidinedione tyrosine-derived PPARγ agonist; it effectively inhibits voltage-dependent calcium channels (VDCC) and relaxes pressurized arteries (IC50 = 3 μM with Ba2+ as charge carrier); it induces mitochondria- and apoptosome-dependent apoptosis, causing rapid mitochondrial membrane depolarization and cytochrome c release in primary pro-B cells and BU-11 cells.